+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Maternal Pertussis Vaccine for Newborn Protection Market - Global Forecast 2026-2032- Product Image
Maternal Pertussis Vaccine for Newborn Protection Market - Global Forecast 2026-2032- Product Image
Sale

Maternal Pertussis Vaccine for Newborn Protection Market - Global Forecast 2026-2032

  • Report

  • 189 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6134305
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Maternal Pertussis Vaccine for Newborn Protection Market is projected to reach USD 2.30 Billion in 2026. It is expected to continue growing at a CAGR of 6.79%, reaching USD 3.42 Billion by 2032.

Maternal Pertussis Vaccination as a Newborn Protection Strategy

Maternal pertussis vaccination is a prevention strategy designed to protect infants during the first months of life, before completion of their own primary immunization series. Vaccination during pregnancy can support transplacental transfer of antibodies and reduce the risk of severe pertussis in newborns. Program performance depends on clinical guidance, timely antenatal care, vaccine confidence, supply continuity, and effective referral and documentation systems.

Pregnancy Care Integration Is Reshaping Pertussis Prevention

The landscape is shifting from stand-alone immunization activity toward integration with routine antenatal services. This places greater emphasis on offering vaccination at the recommended stage of pregnancy, reducing missed opportunities, and ensuring consistent messages from obstetric, midwifery, primary-care, and public-health teams. Delivery models increasingly need to accommodate pharmacy-based services, community outreach, electronic reminders, and catch-up processes for people who begin prenatal care late.

Artificial Intelligence Can Improve Identification and Delivery Workflows

Artificial intelligence can support maternal pertussis vaccination without replacing clinical judgment. Potential applications include identifying patients who may be approaching the recommended vaccination window, flagging incomplete records, optimizing appointment outreach, translating educational materials, and detecting geographic or demographic gaps in uptake. Safe deployment requires validated data, privacy safeguards, bias monitoring, clinician oversight, and clear separation between decision support and autonomous medical advice.

Regional Priorities Differ Across Maternal Immunization Systems

In North America, priorities include maintaining strong prenatal-provider recommendations, improving access for underserved communities, and linking maternal vaccination records across care settings. Latin America may benefit from integration with public antenatal programs, community health networks, and trusted local communication channels. Europe faces the need to align national schedules and sustain confidence across diverse health systems. The Middle East can strengthen delivery through maternity hospitals, primary-care networks, and culturally appropriate counseling. Africa requires attention to antenatal attendance, cold-chain reliability, workforce capacity, and equitable rural access. Asia-Pacific presents varied needs, including urban-rural coverage gaps, fragmented records, and coordination between public and private maternity services.

Multilateral Groups Can Coordinate Standards, Access, and Confidence

ASEAN cooperation can support shared training, cross-border learning, and consistent maternal-immunization communication. BRICS members can exchange approaches to domestic production, procurement resilience, surveillance, and delivery through large public-health systems. The European Union can advance interoperability, evidence communication, and alignment while respecting national program decisions. G7 members can contribute to evidence generation, safety monitoring, and support for resilient supply and implementation systems. GCC countries can leverage integrated hospital networks and coordinated prenatal care pathways. NATO members may strengthen continuity planning and health-system preparedness, particularly where vaccination delivery depends on resilient logistics and interoperable records.

Country Programs Require Context-Specific Implementation Priorities

Australia can focus on consistent antenatal recommendations across public and private providers. Brazil and Mexico can strengthen outreach through primary care and community-based prenatal services. Canada, the United States, the United Kingdom, France, Germany, Italy, and Spain can prioritize equitable access, standardized provider prompts, and accurate recording across fragmented care settings. China and India may benefit from stronger integration between maternal health services and immunization registries, with attention to regional variation. Japan and South Korea can emphasize trusted clinician communication and coordinated prenatal scheduling. Russia can focus on consistent clinical guidance, surveillance, and access across geographically diverse regions.

Leaders Should Embed Vaccination Into Every Eligible Antenatal Encounter

Industry and health-system leaders should establish clear pregnancy-specific protocols, train all relevant prenatal-care staff, and use standing referral or reminder workflows to reduce missed opportunities. They should monitor timeliness, completion, access by population group, adverse-event reporting, and documentation quality rather than relying on procurement or appointment counts alone. Partnerships with maternity facilities, pharmacies, community organizations, and digital-health providers can extend reach, while transparent safety communication and rapid response to misinformation can reinforce confidence. Any AI-enabled workflow should be piloted, independently evaluated, and governed through privacy, equity, and clinical-safety controls.

Evidence Synthesis Focuses on Clinical Guidance and Program Delivery

This executive summary is based on a structured interpretation of established maternal-immunization principles, including passive antibody transfer, antenatal-care integration, vaccine confidence, access, supply continuity, safety monitoring, and health-information interoperability. The analysis organizes implications across the specified regions, country groups, and countries. It does not provide market estimates, market shares, forecasts, or company-level assessments. Country and group observations are framed as implementation considerations rather than claims of identical policy or coverage.

Sustained Newborn Protection Depends on Reliable Antenatal Delivery

Maternal pertussis vaccination is most effective as a coordinated component of prenatal and infant immunization systems. The central priorities are timely recommendation and administration, equitable access, trusted counseling, dependable supply, high-quality records, and continuous safety surveillance. Regional and country programs can improve outcomes by adapting these principles to local care pathways while using responsible digital and AI tools to identify gaps and support follow-up.

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Maternal Pertussis Vaccine for Newborn Protection Market, by Vaccine Type
7.1. Introduction
7.2. Adsorbed Tdap
7.3. Non Aluminum Adjuvanted Tdap
8. Maternal Pertussis Vaccine for Newborn Protection Market, by Dosage Form
8.1. Introduction
8.2. Multi Dose
8.3. Single Dose
9. Maternal Pertussis Vaccine for Newborn Protection Market, by Application
9.1. Introduction
9.2. Maternal Immunization Programs
9.3. Routine Immunization
10. Maternal Pertussis Vaccine for Newborn Protection Market, by Administration Setting
10.1. Introduction
10.2. Inpatient
10.2.1. Private Hospitals
10.2.2. Public Hospitals
10.3. Outpatient
10.3.1. Community Clinics
10.3.2. Home Healthcare
11. Maternal Pertussis Vaccine for Newborn Protection Market, by Route of Administration
11.1. Introduction
11.2. Intramuscular Injection
11.3. Subcutaneous Injection
12. Maternal Pertussis Vaccine for Newborn Protection Market, by Age Group
12.1. Introduction
12.2. 18-24 Years
12.3. 25-34 Years
12.4. 35-44 Years
13. Maternal Pertussis Vaccine for Newborn Protection Market, by End User
13.1. Introduction
13.2. Ambulatory Care Centers
13.2.1. Ambulatory Surgical Centers
13.2.2. Physician Offices
13.3. Clinics
13.3.1. General Clinics
13.3.2. Specialized Clinics
13.4. Hospitals
13.4.1. Private Hospitals
13.4.2. Public Hospitals
14. Maternal Pertussis Vaccine for Newborn Protection Market, by Distribution Channel
14.1. Introduction
14.2. Hospital Pharmacies
14.2.1. Affiliated Hospital Pharmacies
14.2.2. Independent Hospital Pharmacies
14.3. Online Pharmacies
14.3.1. Direct To Consumer
14.3.2. E Pharmacy Platforms
14.4. Retail Pharmacies
14.4.1. Chain Pharmacies
14.4.2. Independent Pharmacies
15. Maternal Pertussis Vaccine for Newborn Protection Market, by Region
15.1. Introduction
15.2. Asia-Pacific
15.3. North America
15.4. Latin America
15.5. Europe
15.6. Middle East
15.7. Africa
16. Maternal Pertussis Vaccine for Newborn Protection Market, by Group
16.1. Introduction
16.2. ASEAN
16.3. GCC
16.4. European Union
16.5. BRICS
16.6. G7
16.7. NATO
17. Maternal Pertussis Vaccine for Newborn Protection Market, by Country
17.1. Introduction
17.2. United States
17.3. Canada
17.4. Mexico
17.5. Brazil
17.6. United Kingdom
17.7. Germany
17.8. France
17.9. Russia
17.10. Italy
17.11. Spain
17.12. China
17.13. India
17.14. Japan
17.15. Australia
17.16. South Korea
18. Competitive Landscape
18.1. Market Share Analysis, 2025
18.2. Market Concentration Analysis, 2025
18.2.1. Concentration Ratio (CR)
18.2.2. Herfindahl Hirschman Index (HHI)
18.3. Recent Developments & Impact Analysis, 2025
18.4. Product Portfolio Analysis, 2025
18.5. Benchmarking Analysis, 2025
19. Company Profiles
19.1. AJ Vaccines A/S
19.2. Astellas Pharma
19.3. Bharat Biotech
19.4. Biological E. Ltd.
19.5. Chongqing Zhifei Biological Products Co., Ltd.
19.6. GlaxoSmithKline (GSK) plc
19.7. MassBiologics
19.8. Meiji Holdings Co. Ltd.
19.9. Merck & Co., Inc.
19.10. Mitsubishi Tanabe Pharma Corporation
19.11. Panacea Biotec Ltd.
19.12. Sanofi
19.13. Serum Institute of India Pvt. Ltd.
19.14. Walvax Biotechnology Co., Ltd.
20. Key Experts
LIST OF FIGURES
FIGURE 1. Global Maternal Pertussis Vaccine for Newborn Protection Market, Years Considered for the Study
FIGURE 2. Global Maternal Pertussis Vaccine for Newborn Protection Market, Research Design
FIGURE 3. Global Maternal Pertussis Vaccine for Newborn Protection Market, Research Framework
FIGURE 4. Global Maternal Pertussis Vaccine for Newborn Protection Market, Data Triangulation
FIGURE 5. Global Maternal Pertussis Vaccine for Newborn Protection Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Maternal Pertussis Vaccine for Newborn Protection Market Size, by Vaccine Type, 2025 vs 2032 (%)
FIGURE 7. Global Maternal Pertussis Vaccine for Newborn Protection Market Size, by Vaccine Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Maternal Pertussis Vaccine for Newborn Protection Market Size, by Dosage Form, 2025 vs 2032 (%)
FIGURE 9. Global Maternal Pertussis Vaccine for Newborn Protection Market Size, by Dosage Form, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Maternal Pertussis Vaccine for Newborn Protection Market Size, by Application, 2025 vs 2032 (%)
FIGURE 11. Global Maternal Pertussis Vaccine for Newborn Protection Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Maternal Pertussis Vaccine for Newborn Protection Market Size, by Administration Setting, 2025 vs 2032 (%)
FIGURE 13. Global Maternal Pertussis Vaccine for Newborn Protection Market Size, by Administration Setting, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Maternal Pertussis Vaccine for Newborn Protection Market Size, by Route of Administration, 2025 vs 2032 (%)
FIGURE 15. Global Maternal Pertussis Vaccine for Newborn Protection Market Size, by Route of Administration, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Maternal Pertussis Vaccine for Newborn Protection Market Size, by Age Group, 2025 vs 2032 (%)
FIGURE 17. Global Maternal Pertussis Vaccine for Newborn Protection Market Size, by Age Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global Maternal Pertussis Vaccine for Newborn Protection Market Size, by End User, 2025 vs 2032 (%)
FIGURE 19. Global Maternal Pertussis Vaccine for Newborn Protection Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 20. Global Maternal Pertussis Vaccine for Newborn Protection Market Size, by Distribution Channel, 2025 vs 2032 (%)
FIGURE 21. Global Maternal Pertussis Vaccine for Newborn Protection Market Size, by Distribution Channel, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 22. Global Maternal Pertussis Vaccine for Newborn Protection Market Size, by Region, 2025 vs 2032 (%)
FIGURE 23. Global Maternal Pertussis Vaccine for Newborn Protection Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 24. Global Maternal Pertussis Vaccine for Newborn Protection Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 25. Global Maternal Pertussis Vaccine for Newborn Protection Market Size, by Country, 2025 vs 2032 (%)
FIGURE 26. Global Maternal Pertussis Vaccine for Newborn Protection Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 27. Global Maternal Pertussis Vaccine for Newborn Protection Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Maternal Pertussis Vaccine for Newborn Protection Market Segmentation & Coverage
TABLE 2. Global Maternal Pertussis Vaccine for Newborn Protection Market Size, 2017-2032 (USD Million)
TABLE 3. Global Maternal Pertussis Vaccine for Newborn Protection Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 4. Global Adsorbed Tdap Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Adsorbed Tdap Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Adsorbed Tdap Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Non Aluminum Adjuvanted Tdap Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Non Aluminum Adjuvanted Tdap Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Non Aluminum Adjuvanted Tdap Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Maternal Pertussis Vaccine for Newborn Protection Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 11. Global Multi Dose Market Size, by Region, 2017-2032 (USD Million)
TABLE 12. Global Multi Dose Market Size, by Group, 2017-2032 (USD Million)
TABLE 13. Global Multi Dose Market Size, by Country, 2017-2032 (USD Million)
TABLE 14. Global Single Dose Market Size, by Region, 2017-2032 (USD Million)
TABLE 15. Global Single Dose Market Size, by Group, 2017-2032 (USD Million)
TABLE 16. Global Single Dose Market Size, by Country, 2017-2032 (USD Million)
TABLE 17. Global Maternal Pertussis Vaccine for Newborn Protection Market Size, by Application, 2017-2032 (USD Million)
TABLE 18. Global Maternal Immunization Programs Market Size, by Region, 2017-2032 (USD Million)
TABLE 19. Global Maternal Immunization Programs Market Size, by Group, 2017-2032 (USD Million)
TABLE 20. Global Maternal Immunization Programs Market Size, by Country, 2017-2032 (USD Million)
TABLE 21. Global Routine Immunization Market Size, by Region, 2017-2032 (USD Million)
TABLE 22. Global Routine Immunization Market Size, by Group, 2017-2032 (USD Million)
TABLE 23. Global Routine Immunization Market Size, by Country, 2017-2032 (USD Million)
TABLE 24. Global Maternal Pertussis Vaccine for Newborn Protection Market Size, by Administration Setting, 2017-2032 (USD Million)
TABLE 25. Global Inpatient Market Size, by Region, 2017-2032 (USD Million)
TABLE 26. Global Inpatient Market Size, by Group, 2017-2032 (USD Million)
TABLE 27. Global Inpatient Market Size, by Country, 2017-2032 (USD Million)
TABLE 28. Global Private Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 29. Global Private Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 30. Global Private Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 31. Global Public Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 32. Global Public Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 33. Global Public Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 34. Global Outpatient Market Size, by Region, 2017-2032 (USD Million)
TABLE 35. Global Outpatient Market Size, by Group, 2017-2032 (USD Million)
TABLE 36. Global Outpatient Market Size, by Country, 2017-2032 (USD Million)
TABLE 37. Global Community Clinics Market Size, by Region, 2017-2032 (USD Million)
TABLE 38. Global Community Clinics Market Size, by Group, 2017-2032 (USD Million)
TABLE 39. Global Community Clinics Market Size, by Country, 2017-2032 (USD Million)
TABLE 40. Global Home Healthcare Market Size, by Region, 2017-2032 (USD Million)
TABLE 41. Global Home Healthcare Market Size, by Group, 2017-2032 (USD Million)
TABLE 42. Global Home Healthcare Market Size, by Country, 2017-2032 (USD Million)
TABLE 43. Global Maternal Pertussis Vaccine for Newborn Protection Market Size, by Route of Administration, 2017-2032 (USD Million)
TABLE 44. Global Intramuscular Injection Market Size, by Region, 2017-2032 (USD Million)
TABLE 45. Global Intramuscular Injection Market Size, by Group, 2017-2032 (USD Million)
TABLE 46. Global Intramuscular Injection Market Size, by Country, 2017-2032 (USD Million)
TABLE 47. Global Subcutaneous Injection Market Size, by Region, 2017-2032 (USD Million)
TABLE 48. Global Subcutaneous Injection Market Size, by Group, 2017-2032 (USD Million)
TABLE 49. Global Subcutaneous Injection Market Size, by Country, 2017-2032 (USD Million)
TABLE 50. Global Maternal Pertussis Vaccine for Newborn Protection Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 51. Global 18-24 Years Market Size, by Region, 2017-2032 (USD Million)
TABLE 52. Global 18-24 Years Market Size, by Group, 2017-2032 (USD Million)
TABLE 53. Global 18-24 Years Market Size, by Country, 2017-2032 (USD Million)
TABLE 54. Global 25-34 Years Market Size, by Region, 2017-2032 (USD Million)
TABLE 55. Global 25-34 Years Market Size, by Group, 2017-2032 (USD Million)
TABLE 56. Global 25-34 Years Market Size, by Country, 2017-2032 (USD Million)
TABLE 57. Global 35-44 Years Market Size, by Region, 2017-2032 (USD Million)
TABLE 58. Global 35-44 Years Market Size, by Group, 2017-2032 (USD Million)
TABLE 59. Global 35-44 Years Market Size, by Country, 2017-2032 (USD Million)
TABLE 60. Global Maternal Pertussis Vaccine for Newborn Protection Market Size, by End User, 2017-2032 (USD Million)
TABLE 61. Global Ambulatory Care Centers Market Size, by Region, 2017-2032 (USD Million)
TABLE 62. Global Ambulatory Care Centers Market Size, by Group, 2017-2032 (USD Million)
TABLE 63. Global Ambulatory Care Centers Market Size, by Country, 2017-2032 (USD Million)
TABLE 64. Global Ambulatory Surgical Centers Market Size, by Region, 2017-2032 (USD Million)
TABLE 65. Global Ambulatory Surgical Centers Market Size, by Group, 2017-2032 (USD Million)
TABLE 66. Global Ambulatory Surgical Centers Market Size, by Country, 2017-2032 (USD Million)
TABLE 67. Global Physician Offices Market Size, by Region, 2017-2032 (USD Million)
TABLE 68. Global Physician Offices Market Size, by Group, 2017-2032 (USD Million)
TABLE 69. Global Physician Offices Market Size, by Country, 2017-2032 (USD Million)
TABLE 70. Global Clinics Market Size, by Region, 2017-2032 (USD Million)
TABLE 71. Global Clinics Market Size, by Group, 2017-2032 (USD Million)
TABLE 72. Global Clinics Market Size, by Country, 2017-2032 (USD Million)
TABLE 73. Global General Clinics Market Size, by Region, 2017-2032 (USD Million)
TABLE 74. Global General Clinics Market Size, by Group, 2017-2032 (USD Million)
TABLE 75. Global General Clinics Market Size, by Country, 2017-2032 (USD Million)
TABLE 76. Global Specialized Clinics Market Size, by Region, 2017-2032 (USD Million)
TABLE 77. Global Specialized Clinics Market Size, by Group, 2017-2032 (USD Million)
TABLE 78. Global Specialized Clinics Market Size, by Country, 2017-2032 (USD Million)
TABLE 79. Global Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 80. Global Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 81. Global Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 82. Global Private Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 83. Global Private Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 84. Global Private Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 85. Global Public Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 86. Global Public Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 87. Global Public Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 88. Global Maternal Pertussis Vaccine for Newborn Protection Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 89. Global Hospital Pharmacies Market Size, by Region, 2017-2032 (USD Million)
TABLE 90. Global Hospital Pharmacies Market Size, by Group, 2017-2032 (USD Million)
TABLE 91. Global Hospital Pharmacies Market Size, by Country, 2017-2032 (USD Million)
TABLE 92. Global Affiliated Hospital Pharmacies Market Size, by Region, 2017-2032 (USD Million)
TABLE 93. Global Affiliated Hospital Pharmacies Market Size, by Group, 2017-2032 (USD Million)
TABLE 94. Global Affiliated Hospital Pharmacies Market Size, by Country, 2017-2032 (USD Million)
TABLE 95. Global Independent Hospital Pharmacies Market Size, by Region, 2017-2032 (USD Million)
TABLE 96. Global Independent Hospital Pharmacies Market Size, by Group, 2017-2032 (USD Million)
TABLE 97. Global Independent Hospital Pharmacies Market Size, by Country, 2017-2032 (USD Million)
TABLE 98. Global Online Pharmacies Market Size, by Region, 2017-2032 (USD Million)
TABLE 99. Global Online Pharmacies Market Size, by Group, 2017-2032 (USD Million)
TABLE 100. Global Online Pharmacies Market Size, by Country, 2017-2032 (USD Million)
TABLE 101. Global Direct To Consumer Market Size, by Region, 2017-2032 (USD Million)
TABLE 102. Global Direct To Consumer Market Size, by Group, 2017-2032 (USD Million)
TABLE 103. Global Direct To Consumer Market Size, by Country, 2017-2032 (USD Million)
TABLE 104. Global E Pharmacy Platforms Market Size, by Region, 2017-2032 (USD Million)
TABLE 105. Global E Pharmacy Platforms Market Size, by Group, 2017-2032 (USD Million)
TABLE 106. Global E Pharmacy Platforms Market Size, by Country, 2017-2032 (USD Million)
TABLE 107. Global Retail Pharmacies Market Size, by Region, 2017-2032 (USD Million)
TABLE 108. Global Retail Pharmacies Market Size, by Group, 2017-2032 (USD Million)
TABLE 109. Global Retail Pharmacies Market Size, by Country, 2017-2032 (USD Million)
TABLE 110. Global Chain Pharmacies Market Size, by Region, 2017-2032 (USD Million)
TABLE 111. Global Chain Pharmacies Market Size, by Group, 2017-2032 (USD Million)
TABLE 112. Global Chain Pharmacies Market Size, by Country, 2017-2032 (USD Million)
TABLE 113. Global Independent Pharmacies Market Size, by Region, 2017-2032 (USD Million)
TABLE 114. Global Independent Pharmacies Market Size, by Group, 2017-2032 (USD Million)
TABLE 115. Global Independent Pharmacies Market Size, by Country, 2017-2032 (USD Million)
TABLE 116. Global Maternal Pertussis Vaccine for Newborn Protection Market Size, by Region, 2017-2032 (USD Million)
TABLE 117. Asia-Pacific Maternal Pertussis Vaccine for Newborn Protection Market Size, by Region, 2017-2032 (USD Million)
TABLE 118. Asia-Pacific Maternal Pertussis Vaccine for Newborn Protection Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 119. Asia-Pacific Maternal Pertussis Vaccine for Newborn Protection Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 120. Asia-Pacific Maternal Pertussis Vaccine for Newborn Protection Market Size, by Application, 2017-2032 (USD Million)
TABLE 121. Asia-Pacific Maternal Pertussis Vaccine for Newborn Protection Market Size, by Administration Setting, 2017-2032 (USD Million)
TABLE 122. Asia-Pacific Maternal Pertussis Vaccine for Newborn Protection Market Size, by Inpatient, 2017-2032 (USD Million)
TABLE 123. Asia-Pacific Maternal Pertussis Vaccine for Newborn Protection Market Size, by Outpatient, 2017-2032 (USD Million)
TABLE 124. Asia-Pacific Maternal Pertussis Vaccine for Newborn Protection Market Size, by Route of Administration, 2017-2032 (USD Million)
TABLE 125. Asia-Pacific Maternal Pertussis Vaccine for Newborn Protection Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 126. Asia-Pacific Maternal Pertussis Vaccine for Newborn Protection Market Size, by End User, 2017-2032 (USD Million)
TABLE 127. Asia-Pacific Maternal Pertussis Vaccine for Newborn Protection Market Size, by Ambulatory Care Centers, 2017-2032 (USD Million)
TABLE 128. Asia-Pacific Maternal Pertussis Vaccine for Newborn Protection Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 129. Asia-Pacific Maternal Pertussis Vaccine for Newborn Protection Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 130. Asia-Pacific Maternal Pertussis Vaccine for Newborn Protection Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 131. Asia-Pacific Maternal Pertussis Vaccine for Newborn Protection Market Size, by Hospital Pharmacies, 2017-2032 (USD Million)
TABLE 132. Asia-Pacific Maternal Pertussis Vaccine for Newborn Protection Market Size, by Online Pharmacies, 2017-2032 (USD Million)
TABLE 133. Asia-Pacific Maternal Pertussis Vaccine for Newborn Protection Market Size, by Retail Pharmacies, 2017-2032 (USD Million)
TABLE 134. North America Maternal Pertussis Vaccine for Newborn Protection Market Size, by Region, 2017-2032 (USD Million)
TABLE 135. North America Maternal Pertussis Vaccine for Newborn Protection Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 136. North America Maternal Pertussis Vaccine for Newborn Protection Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 137. North America Maternal Pertussis Vaccine for Newborn Protection Market Size, by Application, 2017-2032 (USD Million)
TABLE 138. North America Maternal Pertussis Vaccine for Newborn Protection Market Size, by Administration Setting, 2017-2032 (USD Million)
TABLE 139. North America Maternal Pertussis Vaccine for Newborn Protection Market Size, by Inpatient, 2017-2032 (USD Million)
TABLE 140. North America Maternal Pertussis Vaccine for Newborn Protection Market Size, by Outpatient, 2017-2032 (USD Million)
TABLE 141. North America Maternal Pertussis Vaccine for Newborn Protection Market Size, by Route of Administration, 2017-2032 (USD Million)
TABLE 142. North America Maternal Pertussis Vaccine for Newborn Protection Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 143. North America Maternal Pertussis Vaccine for Newborn Protection Market Size, by End User, 2017-2032 (USD Million)
TABLE 144. North America Maternal Pertussis Vaccine for Newborn Protection Market Size, by Ambulatory Care Centers, 2017-2032 (USD Million)
TABLE 145. North America Maternal Pertussis Vaccine for Newborn Protection Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 146. North America Maternal Pertussis Vaccine for Newborn Protection Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 147. North America Maternal Pertussis Vaccine for Newborn Protection Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 148. North America Maternal Pertussis Vaccine for Newborn Protection Market Size, by Hospital Pharmacies, 2017-2032 (USD Million)
TABLE 149. North America Maternal Pertussis Vaccine for Newborn Protection Market Size, by Online Pharmacies, 2017-2032 (USD Million)
TABLE 150. North America Maternal Pertussis Vaccine for Newborn Protection Market Size, by Retail Pharmacies, 2017-2032 (USD Million)
TABLE 151. Latin America Maternal Pertussis Vaccine for Newborn Protection Market Size, by Region, 2017-2032 (USD Million)
TABLE 152. Latin America Maternal Pertussis Vaccine for Newborn Protection Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 153. Latin America Maternal Pertussis Vaccine for Newborn Protection Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 154. Latin America Maternal Pertussis Vaccine for Newborn Protection Market Size, by Application, 2017-2032 (USD Million)
TABLE 155. Latin America Maternal Pertussis Vaccine for Newborn Protection Market Size, by Administration Setting, 2017-2032 (USD Million)
TABLE 156. Latin America Maternal Pertussis Vaccine for Newborn Protection Market Size, by Inpatient, 2017-2032 (USD Million)
TABLE 157. Latin America Maternal Pertussis Vaccine for Newborn Protection Market Size, by Outpatient, 2017-2032 (USD Million)
TABLE 158. Latin America Maternal Pertussis Vaccine for Newborn Protection Market Size, by Route of Administration, 2017-2032 (USD Million)
TABLE 159. Latin America Maternal Pertussis Vaccine for Newborn Protection Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 160. Latin America Maternal Pertussis Vaccine for Newborn Protection Market Size, by End User, 2017-2032 (USD Million)
TABLE 161. Latin America Maternal Pertussis Vaccine for Newborn Protection Market Size, by Ambulatory Care Centers, 2017-2032 (USD Million)
TABLE 162. Latin America Maternal Pertussis Vaccine for Newborn Protection Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 163. Latin America Maternal Pertussis Vaccine for Newborn Protection Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 164. Latin America Maternal Pertussis Vaccine for Newborn Protection Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 165. Latin America Maternal Pertussis Vaccine for Newborn Protection Market Size, by Hospital Pharmacies, 2017-2032 (USD Million)
TABLE 166. Latin America Maternal Pertussis Vaccine for Newborn Protection Market Size, by Online Pharmacies, 2017-2032 (USD Million)
TABLE 167. Latin America Maternal Pertussis Vaccine for Newborn Protection Market Size, by Retail Pharmacies, 2017-2032 (USD Million)
TABLE 168. Europe Maternal Pertussis Vaccine for Newborn Protection Market Size, by Region, 2017-2032 (USD Million)
TABLE 169. Europe Maternal Pertussis Vaccine for Newborn Protection Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 170. Europe Maternal Pertussis Vaccine for Newborn Protection Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 171. Europe Maternal Pertussis Vaccine for Newborn Protection Market Size, by Application, 2017-2032 (USD Million)
TABLE 172. Europe Maternal Pertussis Vaccine for Newborn Protection Market Size, by Administration Setting, 2017-2032 (USD Million)
TABLE 173. Europe Maternal Pertussis Vaccine for Newborn Protection Market Size, by Inpatient, 2017-2032 (USD Million)
TABLE 174. Europe Maternal Pertussis Vaccine for Newborn Protection Market Size, by Outpatient, 2017-2032 (USD Million)
TABLE 175. Europe Maternal Pertussis Vaccine for Newborn Protection Market Size, by Route of Administration, 2017-2032 (USD Million)
TABLE 176. Europe Maternal Pertussis Vaccine for Newborn Protection Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 177. Europe Maternal Pertussis Vaccine for Newborn Protection Market Size, by End User, 2017-2032 (USD Million)
TABLE 178. Europe Maternal Pertussis Vaccine for Newborn Protection Market Size, by Ambulatory Care Centers, 2017-2032 (USD Million)
TABLE 179. Europe Maternal Pertussis Vaccine for Newborn Protection Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 180. Europe Maternal Pertussis Vaccine for Newborn Protection Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 181. Europe Maternal Pertussis Vaccine for Newborn Protection Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 182. Europe Maternal Pertussis Vaccine for Newborn Protection Market Size, by Hospital Pharmacies, 2017-2032 (USD Million)
TABLE 183. Europe Maternal Pertussis Vaccine for Newborn Protection Market Size, by Online Pharmacies, 2017-2032 (USD Million)
TABLE 184. Europe Maternal Pertussis Vaccine for Newborn Protection Market Size, by Retail Pharmacies, 2017-2032 (USD Million)
TABLE 185. Middle East Maternal Pertussis Vaccine for Newborn Protection Market Size, by Region, 2017-2032 (USD Million)
TABLE 186. Middle East Maternal Pertussis Vaccine for Newborn Protection Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 187. Middle East Maternal Pertussis Vaccine for Newborn Protection Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 188. Middle East Maternal Pertussis Vaccine for Newborn Protection Market Size, by Application, 2017-2032 (USD Million)
TABLE 189. Middle East Maternal Pertussis Vaccine for Newborn Protection Market Size, by Administration Setting, 2017-2032 (USD Million)
TABLE 190. Middle East Maternal Pertussis Vaccine for Newborn Protection Market Size, by Inpatient, 2017-2032 (USD Million)
TABLE 191. Middle East Maternal Pertussis Vaccine for Newborn Protection Market Size, by Outpatient, 2017-2032 (USD Million)
TABLE 192. Middle East Maternal Pertussis Vaccine for Newborn Protection Market Size, by Route of Administration, 2017-2032 (USD Million)
TABLE 193. Middle East Maternal Pertussis Vaccine for Newborn Protection Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 194. Middle East Maternal Pertussis Vaccine for Newborn Protection Market Size, by End User, 2017-2032 (USD Million)
TABLE 195. Middle East Maternal Pertussis Vaccine for Newborn Protection Market Size, by Ambulatory Care Centers, 2017-2032 (USD Million)
TABLE 196. Middle East Maternal Pertussis Vaccine for Newborn Protection Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 197. Middle East Maternal Pertussis Vaccine for Newborn Protection Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 198. Middle East Maternal Pertussis Vaccine for Newborn Protection Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 199. Middle East Maternal Pertussis Vaccine for Newborn Protection Market Size, by Hospital Pharmacies, 2017-2032 (USD Million)
TABLE 200. Middle East Maternal Pertussis Vaccine for Newborn Protection Market Size, by Online Pharmacies, 2017-2032 (USD Million)
TABLE 201. Middle East Maternal Pertussis Vaccine for Newborn Protection Market Size, by Retail Pharmacies, 2017-2032 (USD Million)
TABLE 202. Africa Maternal Pertussis Vaccine for Newborn Protection Market Size, by Region, 2017-2032 (USD Million)
TABLE 203. Africa Maternal Pertussis Vaccine for Newborn Protection Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 204. Africa Maternal Pertussis Vaccine for Newborn Protection Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 205. Africa Maternal Pertussis Vaccine for Newborn Protection Market Size, by Application, 2017-2032 (USD Million)
TABLE 206. Africa Maternal Pertussis Vaccine for Newborn Protection Market Size, by Administration Setting, 2017-2032 (USD Million)
TABLE 207. Africa Maternal Pertussis Vaccine for Newborn Protection Market Size, by Inpatient, 2017-2032 (USD Million)
TABLE 208. Africa Maternal Pertussis Vaccine for Newborn Protection Market Size, by Outpatient, 2017-2032 (USD Million)
TABLE 209. Africa Maternal Pertussis Vaccine for Newborn Protection Market Size, by Route of Administration, 2017-2032 (USD Million)
TABLE 210. Africa Maternal Pertussis Vaccine for Newborn Protection Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 211. Africa Maternal Pertussis Vaccine for Newborn Protection Market Size, by End User, 2017-2032 (USD Million)
TABLE 212. Africa Maternal Pertussis Vaccine for Newborn Protection Market Size, by Ambulatory Care Centers, 2017-2032 (USD Million)
TABLE 213. Africa Maternal Pertussis Vaccine for Newborn Protection Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 214. Africa Maternal Pertussis Vaccine for Newborn Protection Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 215. Africa Maternal Pertussis Vaccine for Newborn Protection Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 216. Africa Maternal Pertussis Vaccine for Newborn Protection Market Size, by Hospital Pharmacies, 2017-2032 (USD Million)
TABLE 217. Africa Maternal Pertussis Vaccine for Newborn Protection Market Size, by Online Pharmacies, 2017-2032 (USD Million)
TABLE 218. Africa Maternal Pertussis Vaccine for Newborn Protection Market Size, by Retail Pharmacies, 2017-2032 (USD Million)
TABLE 219. Global Maternal Pertussis Vaccine for Newborn Protection Market Size, by Group, 2017-2032 (USD Million)
TABLE 220. ASEAN Maternal Pertussis Vaccine for Newborn Protection Market Size, by Group, 2017-2032 (USD Million)
TABLE 221. ASEAN Maternal Pertussis Vaccine for Newborn Protection Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 222. ASEAN Maternal Pertussis Vaccine for Newborn Protection Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 223. ASEAN Maternal Pertussis Vaccine for Newborn Protection Market Size, by Application, 2017-2032 (USD Million)
TABLE 224. ASEAN Maternal Pertussis Vaccine for Newborn Protection Market Size, by Administration Setting, 2017-2032 (USD Million)
TABLE 225. ASEAN Maternal Pertussis Vaccine for Newborn Protection Market Size, by Inpatient, 2017-2032 (USD Million)
TABLE 226. ASEAN Maternal Pertussis Vaccine for Newborn Protection Market Size, by Outpatient, 2017-2032 (USD Million)
TABLE 227. ASEAN Maternal Pertussis Vaccine for Newborn Protection Market Size, by Route of Administration, 2017-2032 (USD Million)
TABLE 228. ASEAN Maternal Pertussis Vaccine for Newborn Protection Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 229. ASEAN Maternal Pertussis Vaccine for Newborn Protection Market Size, by End User, 2017-2032 (USD Million)
TABLE 230. ASEAN Maternal Pertussis Vaccine for Newborn Protection Market Size, by Ambulatory Care Centers, 2017-2032 (USD Million)
TABLE 231. ASEAN Maternal Pertussis Vaccine for Newborn Protection Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 232. ASEAN Maternal Pertussis Vaccine for Newborn Protection Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 233. ASEAN Maternal Pertussis Vaccine for Newborn Protection Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 234. ASEAN Maternal Pertussis Vaccine for Newborn Protection Market Size, by Hospital Pharmacies, 2017-2032 (USD Million)
TABLE 235. ASEAN Maternal Pertussis Vaccine for Newborn Protection Market Size, by Online Pharmacies, 2017-2032 (USD Million)
TABLE 236. ASEAN Maternal Pertussis Vaccine for Newborn Protection Market Size, by Retail Pharmacies, 2017-2032 (USD Million)
TABLE 237. GCC Maternal Pertussis Vaccine for Newborn Protection Market Size, by Group, 2017-2032 (USD Million)
TABLE 238. GCC Maternal Pertussis Vaccine for Newborn Protection Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 239. GCC Maternal Pertussis Vaccine for Newborn Protection Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 240. GCC Maternal Pertussis Vaccine for Newborn Protection Market Size, by Application, 2017-2032 (USD Million)
TABLE 241. GCC Maternal Pertussis Vaccine for Newborn Protection Market Size, by Administration Setting, 2017-2032 (USD Million)
TABLE 242. GCC Maternal Pertussis Vaccine for Newborn Protection Market Size, by Inpatient, 2017-2032 (USD Million)
TABLE 243. GCC Maternal Pertussis Vaccine for Newborn Protection Market Size, by Outpatient, 2017-2032 (USD Million)
TABLE 244. GCC Maternal Pertussis Vaccine for Newborn Protection Market Size, by Route of Administration, 2017-2032 (USD Million)
TABLE 245. GCC Maternal Pertussis Vaccine for Newborn Protection Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 246. GCC Maternal Pertussis Vaccine for Newborn Protection Market Size, by End User, 2017-2032 (USD Million)
TABLE 247. GCC Maternal Pertussis Vaccine for Newborn Protection Market Size, by Ambulatory Care Centers, 2017-2032 (USD Million)
TABLE 248. GCC Maternal Pertussis Vaccine for Newborn Protection Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 249. GCC Maternal Pertussis Vaccine for Newborn Protection Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 250. GCC Maternal Pertussis Vaccine for Newborn Protection Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 251. GCC Maternal Pertussis Vaccine for Newborn Protection Market Size, by Hospital Pharmacies, 2017-2032 (USD Million)
TABLE 252. GCC Maternal Pertussis Vaccine for Newborn Protection Market Size, by Online Pharmacies, 2017-2032 (USD Million)
TABLE 253. GCC Maternal Pertussis Vaccine for Newborn Protection Market Size, by Retail Pharmacies, 2017-2032 (USD Million)
TABLE 254. European Union Maternal Pertussis Vaccine for Newborn Protection Market Size, by Group, 2017-2032 (USD Million)
TABLE 255. European Union Maternal Pertussis Vaccine for Newborn Protection Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 256. European Union Maternal Pertussis Vaccine for Newborn Protection Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 257. European Union Maternal Pertussis Vaccine for Newborn Protection Market Size, by Application, 2017-2032 (USD Million)
TABLE 258. European Union Maternal Pertussis Vaccine for Newborn Protection Market Size, by Administration Setting, 2017-2032 (USD Million)
TABLE 259. European Union Maternal Pertussis Vaccine for Newborn Protection Market Size, by Inpatient, 2017-2032 (USD Million)
TABLE 260. European Union Maternal Pertussis Vaccine for Newborn Protection Market Size, by Outpatient, 2017-2032 (USD Million)
TABLE 261. European Union Maternal Pertussis Vaccine for Newborn Protection Market Size, by Route of Administration, 2017-2032 (USD Million)
TABLE 262. European Union Maternal Pertussis Vaccine for Newborn Protection Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 263. European Union Maternal Pertussis Vaccine for Newborn Protection Market Size, by End User, 2017-2032 (USD Million)
TABLE 264. European Union Maternal Pertussis Vaccine for Newborn Protection Market Size, by Ambulatory Care Centers, 2017-2032 (USD Million)
TABLE 265. European Union Maternal Pertussis Vaccine for Newborn Protection Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 266. European Union Maternal Pertussis Vaccine for Newborn Protection Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 267. European Union Maternal Pertussis Vaccine for Newborn Protection Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 268. European Union Maternal Pertussis Vaccine for Newborn Protection Market Size, by Hospital Pharmacies, 2017-2032 (USD Million)
TABLE 269. European Union Maternal Pertussis Vaccine for Newborn Protection Market Size, by Online Pharmacies, 2017-2032 (USD Million)
TABLE 270. European Union Maternal Pertussis Vaccine for Newborn Protection Market Size, by Retail Pharmacies, 2017-2032 (USD Million)
TABLE 271. BRICS Maternal Pertussis Vaccine for Newborn Protection Market Size, by Group, 2017-2032 (USD Million)
TABLE 272. BRICS Maternal Pertussis Vaccine for Newborn Protection Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 273. BRICS Maternal Pertussis Vaccine for Newborn Protection Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 274. BRICS Maternal Pertussis Vaccine for Newborn Protection Market Size, by Application, 2017-2032 (USD Million)
TABLE 275. BRICS Maternal Pertussis Vaccine for Newborn Protection Market Size, by Administration Setting, 2017-2032 (USD Million)
TABLE 276. BRICS Maternal Pertussis Vaccine for Newborn Protection Market Size, by Inpatient, 2017-2032 (USD Million)
TABLE 277. BRICS Maternal Pertussis Vaccine for Newborn Protection Market Size, by Outpatient, 2017-2032 (USD Million)
TABLE 278. BRICS Maternal Pertussis Vaccine for Newborn Protection Market Size, by Route of Administration, 2017-2032 (USD Million)
TABLE 279. BRICS Maternal Pertussis Vaccine for Newborn Protection Market Size, by Age Group, 2017-2032 (USD Million)
TABLE 280. BRICS Maternal Pertussis Vaccine for Newborn Protection Market Size, by End User, 2017-2032 (USD Million)
TABLE 281. BRICS Maternal Pertussis Vaccine for Newborn Protection Market Size, by Ambulatory Care Centers, 2017-2032 (USD Million)
TABLE 282. BRICS Maternal Pertussis Vaccine for Newborn Protection Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 283. BRICS Maternal Pertussis Vaccine for Newborn Protection Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 284. BRICS Maternal Pertussis Vaccine for Newborn Protection Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 285. BRICS Maternal Pertussis Vaccine for Newborn Protection Market Size, by Hospital Pharmacies, 2017-2032 (USD Million)
TABLE 286. BRICS Maternal Pertussis Vaccine for Newborn Protection Market Size, by Online Pharmacies, 2017-2032 (USD Million)
TABLE 287. BRICS Maternal Pertussis Vaccine for Newborn Protection Market Size, by Retail Pharmacies, 2017-2032 (USD Million)
TABLE 288. G7 Maternal Pertussis Vaccine for Newborn Protection Market Size, by Group, 2017-2032 (USD Million)
TABLE 289. G7 Maternal Pertussis Vaccine for Newborn Protection Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 290. G7 Maternal Pertussis Vaccine for Newborn Protection Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 291. G7 Maternal Pertussis Vaccine for Newborn Protection Market Size, by Application, 2017-2032 (USD Million)
TABLE 292. G7 Maternal Pertussis Vaccine for Newborn Protection Market Size, by Administration Setting, 2017-2032 (USD Million)
TABLE 293. G7 Maternal Pertussis Vaccine for Newborn Protection Market Size, by Inpatient, 2017-2032 (USD Million)
TABLE 294. G7 Maternal Pertussis Vaccine for Newborn Protection Market Size, by Outpatient, 2017-2032 (USD Million)
TABLE 295. G7 Maternal Pertussis Vaccine for Newborn Protection Market Size, by Route of Administration, 2017-2032 (USD Million)
TABLE 296. G7 Maternal Pertussis Vaccine for Newborn Protection Market Size, by Age Group, 2017-2032 (USD Millio

Companies Mentioned

  • AJ Vaccines A/S
  • Astellas Pharma
  • Bharat Biotech
  • Biological E. Ltd.
  • Chongqing Zhifei Biological Products Co., Ltd.
  • GlaxoSmithKline (GSK) plc
  • MassBiologics
  • Meiji Holdings Co. Ltd.
  • Merck & Co., Inc.
  • Mitsubishi Tanabe Pharma Corporation
  • Panacea Biotec Ltd.
  • Sanofi
  • Serum Institute of India Pvt. Ltd.
  • Walvax Biotechnology Co., Ltd.

Related Topics

Related Reports

Pertussis Vaccine Market Report 2026 - Product Image

Pertussis Vaccine Market Report 2026

  • Report
  • 250 Pages
  • Global
From
Pertussis Vaccines Market - Global Strategic Business Report - Product Image

Pertussis Vaccines Market - Global Strategic Business Report

  • Report
  • 285 Pages
  • Global
From
Bordetella pertussis (Whooping Cough) Tests Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2036 - Product Image

Bordetella pertussis (Whooping Cough) Tests Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2036

  • Report
  • 52 Pages
  • Global
From
Pertussis Vaccine Market Outlook 2025-2034: Market Share, and Growth Analysis - Product Image

Pertussis Vaccine Market Outlook 2025-2034: Market Share, and Growth Analysis

  • Report
  • 160 Pages
  • Global
From
Boostrix Market Report 2026: Epidemiology, Pipeline Analysis, Market Insights & Forecasts - Product Image

Boostrix Market Report 2026: Epidemiology, Pipeline Analysis, Market Insights & Forecasts

  • Report
  • 250 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.